Fine vs. coarse atrial fibrillation: Which one is more risky?

Cardiology

Volumn 107, Issue 3, 2007, Pages 193-196

  Yilmaz, Mehmet Birhan ^a,c   Guray, Yesim ^b   Guray, Umit ^b   Cay, Serkan ^b   Caldir, Vedat ^b   Biyikoglu, Senay Funda ^b   Sasmaz, Hatice ^b   Korkmaz, Sule ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Yuksek Ihtisas Education and Research Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Atrial fibrillation; Coarse atrial fibrillation; Fine atrial fibrillation

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; COARSE ATRIUM FIBRILLATION; DISEASE ASSOCIATION; FEMALE; FINE ATRIUM FIBRILLATION; HEART ATRIUM FIBRILLATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; ELECTROCARDIOGRAPHY; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34147161700     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095416     Document Type: Article

References (9)

1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001;104:2118-2150.
2. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
3. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ: Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:429S-456S.
4. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
5. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
6. Thurmann M, Janney JG Jr: The diagnostic importance of fibrillatory wave size. Circulation 1962;25:991-994.
7. Li YH, Hwang JJ, Tseng YZ, Kuan P, Lien WP: Clinical significance of fibrillatory wave amplitude. A clue to left atrial appendage function in nonrheumatic atrial fibrillation. Chest 1995;108:359-363.
8. Mutlu B, Karabulut M, Eroglu E, Tigen K, Bayrak F, Fotbolcu H, Basaran Y: Fibrillatory wave amplitude as a marker of left atrial and left atrial appendage function, and a predictor of thromboembolic risk in patients with rheumatic mitral stenosis. Int J Cardiol 2003;91:179-186.
9. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P: Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004;110:2287-2292.